Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-780
Published Online: 2014-10-24
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saw, Robyn PM
Armstrong, Bruce K
Mason, Rebecca S
Morton, Rachael L
Shannon, Kerwin F
Spillane, Andrew J
Stretch, Jonathan R
Thompson, John F
License valid from 2014-10-24